Settlement Spotlight
Active Investigations
-
California Early Termination Fee (ETF) Class Action Lawsuit Investigation
-
Depakote Birth Defect Class Action Lawsuit Investigation
-
Dilantin Class Action Lawsuit Investigation
-
Drywall Price-Fixing, Antitrust Class Action Lawsuit Investigation
-
Kidney Dialysis Heart Attack, GranuFlo & NaturaLyte Recall Class Action Lawsuit Settlement Investigation
-
Mesothelioma Asbestos Class Action Lawsuit Settlement Investigation
-
Metal on Metal Replacement Hip Implant Class Action Lawsuit Investigation
-
Mirena IUD Injury Class Action Lawsuit Settlement Investigation
-
Propecia Loss of Sex Drive, Sexual Dysfunction Class Action Lawsuit Settlement Investigation
-
Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation
-
Text Message Spam, Cell Phone Call TCPA Class Action Lawsuit Settlement Investigation
-
Type 2 Diabetes Drugs Januvia, Byetta Class Action Lawsuit Investigation
-
Unum/UnumProvident Disability Insurance Claim Denial Class Action Lawsuit Investigation
-
Vaginal Mesh Sling Class Action Lawsuit Investigation
-
Wage & Hour, Unpaid Overtime Class Action Lawsuit Investigation
-
Yaz/Yasmin, Ocella & Beyaz Birth Control Class Action Lawsuit Settlement Investigation
-
Zithromax Z-Pak Azithromycin Class Action Lawsuit Settlement Investigation
-
Zoloft & SSRI Antidepressant Birth Defect Class Action Lawsuit Investigation
Top Settlements
Top News
Top Drug Lawsuits
Class Action Lawsuit and Settlement News
| Skechers $40M Toning Shoe Class Action Settlement Preliminarily Approved |
|
|
- Thursday, 16 August 2012 11:41
Skechers $40M Toning Shoe Class Action Settlement Preliminarily Approved
By Kimberly Mirando
A federal judge this week tentatively approved a $40 million class action lawsuit settlement between Skechers USA, Inc. and consumers who bought Skechers toning shoes based on ads that made unfounded claims that the footwear would help people lose weight and strengthen muscles. The class action settlement was reached just three months after Skechers reached a deal with the Federal Trade Commission over the deceptive toning shoes ads. The Skechers toning shoe settlement will provide consumers refunds for their purchases: up to $80 per pair of Shape-Ups; $84 per pair of Resistance Runner shoes; up to $54 per pair of Podded Sole Shoes; and $40 per pair for Tone-Ups. Consumers who purchased these shoes since August 1, 2008 can file a claim to participate in the class action settlement.
The Skechers class action lawsuit settlement covers more than 70 lawsuits filed across the country that were consolidated in federal court in Louisville, Kentucky as Grabowski v. Skechers U.S.A., Inc.
“Skechers’ unfounded claims went beyond stronger and more toned muscles. The company even made claims about weight loss and cardiovascular health,” said David Vladeck, Director of the FTC’s Bureau of Consumer Protection.
In addition to paying out refunds to consumers, Skechers is barred from making claims about strengthening, weight loss, and other health and fitness-related claims for its toning shoes unless they are true and backed by scientific evidence. The Skechers class action settlement also bars the company from misrepresenting any tests, studies or research results regarding toning shoes.
The total refund you can receive from the Skechers shape-ups class action lawsuit settlement will depend on how many Eligible Shoes you purchased since August 1, 2008, as well as the total number of valid claim forms submitted by other Class Members.
To file a claim form for the Skechers Shape-Ups, Resistance Runner, Shape-Ups Toners/Trainers, and Tone-Ups Class Action Settlement, go to www.SkechersSettlement.com.
Updated August 16th, 2012
All class action and lawsuit news updates are listed in the Lawsuit News section of Top Class Actions
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
Top Class Actions Legal Statement
©2008 - 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners
Last Updated on Thursday, 27 December 2012 11:09




Comments
RSS feed for comments to this post